Senses, K. M. Et Al. 2017. Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma. MedChemComm , vol.8, no.1 , 88-95.

Senses, K. M., Ghasemi, M., Akbar, M. W., Isbilen, M., Fallacara, A. L., Frankenburg, S., ... Schenone, S.(2017). Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma. MedChemComm , vol.8, no.1, 88-95.

Senses, Kerem Et Al. "Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma," MedChemComm , vol.8, no.1, 88-95, 2017

Senses, Kerem M. Et Al. "Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma." MedChemComm , vol.8, no.1, pp.88-95, 2017

Senses, K. M. Et Al. (2017) . "Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma." MedChemComm , vol.8, no.1, pp.88-95.

@article{article, author={Kerem M. Senses Et Al. }, title={Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma}, journal={MedChemComm}, year=2017, pages={88-95} }